CTF in the NewsPharma Children’s Tumor Foundation Featured in Two-Part Series in BioSpace on Reviving Abandoned Drugs for Rare Disease Treatments
AdvocacyAwarenessFeaturedFeatured EUPharma From NF to the World: Rare Disease Day and the Race for Faster Treatments
Collaborations & PartnershipsFeaturedFeatured EUNF1PharmaPress ReleaseScience & Research Healx Announces First Patient Dosed in Phase 2 Trial Evaluating HLX-1502 for the Treatment of NF1
Collaborations & PartnershipsFeaturedFeatured EUNF1PharmaPress ReleaseScience & Research CureAge Therapeutics Launches to Advance Genetic Therapies for Neurofibromatosis
AdvocacyFeaturedPharmaStory of NFVideo Give for Treatment Options: Lilly’s Advocacy for Cutaneous Neurofibroma Treatments
FeaturedNF1PharmaStory of NFVideo Give for Tomorrow: Marcia’s Story and the Promise of More Treatments
Collaborations & PartnershipsFeaturedFeatured EUNF1PharmaScience & Research FDA Grants Fast Track Designation to Healx NF1 Treatment
FeaturedFeatured EUNF1PharmaPress Release FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug for NF1 Patients
Featured EUGlobalPharma Nathalie Moll, Director General of EFPIA, Delivered the Opening Address at the Global NF Conference
